GSK recognized for showcasing inclusion in practice on Seramount index

Seramount unveiled its fifth annual Inclusion Index today. The Inclusion Index helps organizations understand trends and gaps in demographic representation, creates a road map to drive internal change, and identifies diversity, equity, and inclusion (DE&I) solutions to close the gaps.

Organizations provided data and were measured in three key areas: best practices in recruitment, retention, and advancement of people from historically underrepresented groups—women, racial/ethnic minorities, people with disabilities, and LGBTQ+ people; inclusive corporate culture, including leadership accountability; and demographic diversity for women and racial/ethnic minorities. This year, questions on how organizations are addressing racism were included in the survey.

Our company was among the 44 organizations recognized for creating an inclusive workplace, receiving a 60 percent or higher score.

“The need to address inclusion in the workplace continues to be a priority for corporate America,” says Katie Oertli Mooney, Vice President of Diversity Best Practices at Seramount. “Progress has been made, but we must remain steadfast in our efforts. We are proud to recognize our Inclusion Index companies for their dedication and for putting in the necessary work to effect real, sustainable change.”

As a company which improves the lives of hundreds of millions of people globally with our medicines, vaccines and consumer products, inclusion and diversity are integral to the way we do business. We strive for our company to be a place where diversity of people and thought is valued everywhere and where we’re all able to feel a sense of belonging. At GSK, we hold ourselves accountable for ensuring that respect and inclusivity are at the very heart of our culture as a company. You can learn more about our I&D efforts here.